EED mutants impair polycomb repressive complex 2 in myelodysplastic syndrome and related neoplasms

A map of human genome variation from population-scale sequencing.

The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · see citing works

The Polycomb complex PRC2 and its mark in life

Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347 · see citing works

Mechanisms of Polycomb gene silencing: knowns and unknowns

Simon, J. A., & Kingston, R. E. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2763 · Cited by 1,320 · see citing works

Mutations of optineurin in amyotrophic lateral sclerosis

Maruyama, H., Morino, H., Ito, H., Izumi, Y., Kato, H., Watanabe, Y., Kinoshita, Y., Kamada, M., Nodera, H., Suzuki, H., et al. (2010) · Nature · doi:10.1038/nature08971 · Cited by 1,265 · see citing works

Role of the polycomb protein EED in the propagation of repressive histone marks

Margueron, R., Justin, N., Ohno, K., Sharpe, M. L., Son, J., Drury, W. J., Voigt, P., Martin, S. R., Taylor, W. R., Marco, V. D., et al. (2009) · Nature · doi:10.1038/nature08398 · Cited by 1,203 · see citing works

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders

Ernst, T., Chase, A. J., Score, J., Hidalgo-Curtis, C. E., Bryant, C., Jones, A. V., Waghorn, K., Zoi, K., Ross, F. M., Reiter, A., et al. (2010) · Nature Genetics · doi:10.1038/ng.621 · Cited by 1,139 · see citing works

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes

Nikoloski, G., Langemeijer, S. M. C., Kuiper, R. P., Knops, R., Massop, M., Tönnissen, E., van der Heijden, A., Scheele, T. N., Vandenberghe, P., de Witte, T., et al. (2010) · Nature Genetics · doi:10.1038/ng.620 · Cited by 754 · see citing works

Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms

Sanada, M., Suzuki, T., Shih, L., Otsu, M., Kato, M., Yamazaki, S., Tamura, A., Honda, H., Sakata‐Yanagimoto, M., Kumano, K., et al. (2009) · Nature · doi:10.1038/nature08240 · Cited by 401 · see citing works

Functional antagonism of the polycomb-group genes eed and Bmi1 in hemopoietic cell proliferation

Lessard, J., Schumacher, A., Thorsteinsdottir, U., van Lohuizen, M., Magnuson, T., & Sauvageau, G. (1999) · Genes & Development · doi:10.1101/gad.13.20.2691 · Cited by 219 · see citing works

Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies

Makishima, H., Jankowska, A. M., Tiu, R. V., Szpurka, H., Sugimoto, Y., Hu, Z., Saunthararajah, Y., Guinta, K., Keddache, M. A., Putnam, P., et al. (2010) · Leukemia · doi:10.1038/leu.2010.167 · Cited by 179 · see citing works

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Score, J., Hidalgo-Curtis, C., Jones, A. V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Ernst, T., Stegelmann, F., Döhner, K., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367243 · Cited by 177 · see citing works

Point Mutations in the WD40 Domain of Eed Block Its Interaction with Ezh2

Denisenko, O., Shnyreva, M., Suzuki, H., & Bomsztyk, K. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5634 · Cited by 98 · see citing works

Molecular and Functional Mapping of EED Motifs Required for PRC2-Dependent Histone Methylation

Montgomery, N. D., Yee, D., Montgomery, S. A., & Magnuson, T. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.10.040 · Cited by 51 · see citing works

Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type–specific cancer genes in leukemia

Sauvageau, M., Miller, M., Lemieux, S., Lessard, J. A., Hébert, J., & Sauvageau, G. (2007) · Blood · doi:10.1182/blood-2007-07-098236 · Cited by 35 · see citing works

Targeting EZH2 in cancer

Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471 · see citing works

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

Burr, M. L., Sparbier, C. E., Chan, K. L., Chan, Y.-C., Kersbergen, A. J., Lam, E. Y. N., Azidis-Yates, E., Vassiliadis, D., Bell, C. C., Gilan, O., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.008 · Cited by 656 · see citing works

The roles of DNA, RNA and histone methylation in ageing and cancer

Michalak, E. M., Burr, M. L., Bannister, A. J., & Dawson, M. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0143-1 · Cited by 549 · see citing works

Maintaining cell identity: PRC2-mediated regulation of transcription and cancer

Comet, I. V., Riising, E. M., Leblanc, B., & Helin, K. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.83 · Cited by 428 · see citing works

Chromatin repressive complexes in stem cells, development, and cancer

Laugesen, A., & Helin, K. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.05.006 · Cited by 352 · see citing works

Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner

Xie, H., Xu, J., Hsu, J. H.-R., Nguyen, M., Fujiwara, Y., Peng, C., & Orkin, S. H. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.10.001 · Cited by 320 · see citing works

Epigenetic control of adult stem cell function

Avgustinova, A., & Benitah, S. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.76 · Cited by 216 · see citing works

The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex

He, Y., Selvaraju, S., Curtin, M. L., Jakob, C. G., Zhu, H., Comess, K. M., Shaw, B., The, J., Lima-Fernandes, E., Szewczyk, M. M., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2306 · Cited by 224 · see citing works

Interplay between chromatin marks in development and disease

Janssen, S. M., & Lorincz, M. C. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00416-x · Cited by 141 · see citing works

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies

He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00924-z · Cited by 126 · see citing works

Genetic abnormalities and pathophysiology of MDS

Hosono, N. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01462-6 · Cited by 108 · see citing works

Molecular Pathways: Deregulation of Histone H3 Lysine 27 Methylation in Cancer—Different Paths, Same Destination

Ezponda, T., & Licht, J. D. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2499 · Cited by 96 · see citing works

Epigenetics of myelodysplastic syndromes

Itzykson, R., & Fenaux, P. (2013) · Leukemia · doi:10.1038/leu.2013.343 · Cited by 90 · see citing works

PRC2‐complex related dysfunction in overgrowth syndromes: A review of EZH2 , EED , and SUZ12 and their syndromic phenotypes

Cyrus, S. S., Burkardt, D. D., Weaver, D. D., & Gibson, W. T. (2019) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31754 · Cited by 78 · see citing works

H3K27 Methylation

Nichol, J. N., Dupéré-Richer, D., Ezponda, T., Licht, J. D., & Miller, W. H. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.001 · Cited by 67 · see citing works

Polycomb complexes in normal and malignant hematopoiesis

Carlo, V. D., Mocavini, I., & Croce, L. D. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201808028 · Cited by 61 · see citing works

Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer

Martin, M. C., Zeng, G., Yu, J., & Schiltz, G. E. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01344 · Cited by 62 · see citing works

The controversial role of the Polycomb group proteins in transcription and cancer: how much do we not understand Polycomb proteins?

Scelfo, A., Piunti, A., & Pasini, D. (2014) · FEBS Journal · doi:10.1111/febs.13112 · Cited by 58 · see citing works

Regulating Methylation at H3K27: A Trick or Treat for Cancer Cell Plasticity

Das, P., & Taube, J. H. (2020) · Cancers · doi:10.3390/cancers12102792 · Cited by 57 · see citing works

Polycomb group proteins and MYC: the cancer connection

Benetatos, L., Vartholomatos, G., & Hatzimichael, E. C. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1426-x · Cited by 56 · see citing works

Loss-of-function mutations in the histone methyltransferase EZH2 promote chemotherapy resistance in AML

Kempf, J., Weser, S., Bartoschek, M. D., Metzeler, K. H., Vick, B., Herold, T., Völse, K., Mattes, R., Scholz, M., Wange, L. E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84708-6 · Cited by 50 · see citing works

Targeting PRC2 for the treatment of cancer: an updated patent review (2016 - 2020)

Dockerill, M., Gregson, C. L., & O’Donovan, D. H. (2020) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1841167 · Cited by 46 · see citing works

Epigenetic Regulation of Intestinal Stem Cells and Disease: A Balancing Act of DNA and Histone Methylation

Lorzadeh, A., Romero-Wolf, M., Goel, A., & Jadhav, U. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.03.036 · Cited by 37 · see citing works

Functional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2

Mozzetta, C., Pontis, J., & Ait‐Si‐Ali, S. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6116 · Cited by 37 · see citing works

Loss of microglial EED impairs synapse density, learning, and memory

Wang, Y.-Y., Deng, Y.-S., Dai, S.-K., Mi, T.-W., Li, R.-Y., Liu, P.-P., Liu, C., He, B.-D., He, X.-C., Du, H.-Z., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01576-w · Cited by 32 · see citing works

Depletion of polycomb repressive complex 2 core component EED impairs fetal hematopoiesis

Yu, W., Zhang, F., Wang, S., Fu, Y., Chen, J., Liang, X., Le, H., Pu, W. T., & Zhang, B. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.163 · Cited by 30 · see citing works

Epigenetic Modifiers in Normal and Malignant Hematopoiesis

Haladyna, J. N., Yamauchi, T., Neff, T., & Bernt, K. M. (2015) · Epigenomics · doi:10.2217/epi.14.88 · Cited by 29 · see citing works

Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression

Ueda, T., Nakata, Y., Nagamachi, A., Yamasaki, N., Kanai, A., Sera, Y., Sasaki, M., Matsui, H., Honda, Z., Oda, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600070113 · Cited by 27 · see citing works

Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma

Wasenang, W., Puapairoj, A., Settasatian, C., Proungvitaya, S., & Limpaiboon, T. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152451 · Cited by 24 · see citing works

Targeting EED as a key PRC2 complex mediator toward novel epigenetic therapeutics

Bao, Q., Kumar, A., V, Wu, D., & Zhou, J. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103986 · Cited by 22 · see citing works

Three additional patients with EED-associated overgrowth: potential mutation hotspots identified?

Spellicy, C. J., Peng, Y., Olewiler, L., Cathey, S. S., Rogers, R. C., Bartholomew, D., Johnson, J., Alexov, E. G., Lee, J. A., Friez, M. J., et al. (2019) · Journal of Human Genetics · doi:10.1038/s10038-019-0585-5 · Cited by 22 · see citing works

Polycomb and Trithorax Group Proteins: The Long Road from Mutations in Drosophila to Use in Medicine

Chetverina, D., Ломаев, Д. В., & Erokhin, M. (2020) · Acta Naturae · doi:10.32607/actanaturae.11090 · Cited by 19 · see citing works

Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer

Dong, G., Xu, J., Qi, Y.-R., Yuan, Z., & Zhao, W. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179574 · Cited by 19 · see citing works

Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs

Zhao, Y., Guan, Y., Zhao, F., Yu, T., Zhang, S., Zhang, Y., Duan, Y., & Zhou, X. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114144 · Cited by 18 · see citing works

Disturbing the histone code in leukemia: translocations and mutations affecting histone methyl transferases

Chopra, M., & Bohlander, S. K. (2014) · Cancer Genetics · doi:10.1016/j.cancergen.2014.10.005 · Cited by 17 · see citing works

Approaching the catalytic mechanism of protein lysine methyltransferases by biochemical and simulation techniques

Schnee, P., Pleiss, J., & Jeltsch, A. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2318547 · Cited by 17 · see citing works

Discovery of selective activators of PRC2 mutant EED-I363M

Suh, J. L., Barnash, K. D., Abramyan, T. M., Li, F., The, J., Engelberg, I. A., Vedadi, M., Brown, P. J., Kireev, D., Arrowsmith, C. H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43005-z · Cited by 15 · see citing works

Maintenance of the functional integrity of mouse hematopoiesis by EED and promotion of leukemogenesis by EED haploinsufficiency

Ikeda, K., Ueda, T., Yamasaki, N., Nakata, Y., Sera, Y., Nagamachi, A., Miyama, T., Kobayashi, H., Takubo, K., Kanai, A., et al. (2016) · Scientific Reports · doi:10.1038/srep29454 · Cited by 15 · see citing works

Molecular Genetic Biomarkers in Myeloid Malignancies

Matynia, A. P., Szankasi, P., Shen, W., & Kelley, T. W. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0096-ra · Cited by 14 · see citing works

Polycomb repressive complex 2 (PRC2) pathway’s role in cancer cell plasticity and drug resistance

Goleij, P., Heidari, M. M., Tabari, M. A. K., Hadipour, M., Rezaee, A., Javan, A., Sanaye, P. M., Larsen, D. S., Daglia, M., & Khan, H. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01563-8 · Cited by 11 · see citing works

Knockdown of NIR Suppresses Breast Cancer Cell Proliferation via Promoting FOXO3

Chen, B., Dong, C., Wang, F., & Wu, J. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s287464 · Cited by 7 · see citing works

Identification of novel EED-EZH2 PPI inhibitors using an in silico fragment mapping method

Misawa, K., Yamaotsu, N., & Hirono, S. (2021) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-021-00378-6 · Cited by 7 · see citing works

JMJD3-mediated senescence is required to overcome stress-induced hematopoietic defects

Nakata, Y., Ueda, T., Sera, Y., Koizumi, M., Imamura, K., Kanai, A., Ikeda, K., Yamasaki, N., Nagamachi, A., Kobatake, K., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00502-9 · Cited by 5 · see citing works

Genetic Impairments of PRC2 Activity in Oncology: Problems and Prospects

Chetverina, D., Ломаев, Д. В., Georgiev, P. G., & Erokhin, M. (2021) · Russian Journal of Genetics · doi:10.1134/s1022795421030042 · Cited by 5 · see citing works

Loss of Polycomb Repressive Complex 2 Function Alters Digestive Organ Homeostasis and Neuronal Differentiation in Zebrafish

Raby, L., Völkel, P., Hasanpour, S., Cicero, J., Toillon, R., Adriaenssens, É., SEUNINGEN, I. V., Bourhis, X. L., & Angrand, P. (2021) · Cells · doi:10.3390/cells10113142 · Cited by 4 · see citing works

Structural landscape of H3K27me3 recognition by protein domains and their potential for inhibition

Rosas, R., Baracaldo-Lancheros, L. F., Dykhuizen, E. C., & Musselman, C. A. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111344 · Cited by 2 · see citing works

Polycomb Repressive Complex 2 in Oncology

Guo, Y., Yu, Y., & Wang, G. G. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-45654-1_9 · Cited by 2 · see citing works

Polycomb Proteins in Hematopoiesis and Hematologic Malignancie

Li, J. (2017) · International Journal of Blood Research and Disorders · doi:10.23937/2469-5696/1410025 · Cited by 1 · see citing works

The Role of Polycomb Group Proteins in Hematopoietic Stem Cell (HSC) Self-Renewal and Leukemogenesis

van den Boom, V., Schepers, H., Brouwers-Vos, A. Z., & Schuringa, J. J. (2014) · Epigenetics and human health · doi:10.1007/978-3-642-45198-0_6

Differentielle Methylierung von H3K27 in EZH2 positiven large cell neuroendokrinen Tumoren des Thymus

Kurzen, E. M. (2023) · doi:10.53846/goediss-9690

Mimicking Human EED Variants in Drosophila: A Promising Strategy to Analyse Human EED Variant FunctionPreprint

Cyrus, S. S., Giró, S. M., Lian, T., Allan, D. W., & Gibson, W. T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.18.580839

Functional analysis of human EED variants using Drosophila

Cyrus, S. S., Giró, S. M., Lian, T., Allan, D. W., & Gibson, W. T. (2025) · Genetics · doi:10.1093/genetics/iyaf120

PLZF et les protéines du groupe Polycomb : interaction et implication dans la différenciation hématopoïétique normale et pathologique

Koubi, M. (2015) · doi:10.70675/bdadfd18z7fa2z4308z9766z350d291b246d

LncRNA CASC15 ‐ EZH2 Interaction Promotes Ischemia–Reperfusion Induced Acute Kidney Injury via Regulating SALL1 and Wnt/β‐Catenin Pathway

Zhang, M., Yan, X., Mei, S., Ye, Z., Li, B., Yang, S. H., Zhang, M. Q., Chi, M., Wu, M., Li, H., et al. (2026) · The FASEB Journal · doi:10.1096/fj.202600634r

BindingDB Entry 50013076: Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer.

BindingDB (2022) · UC San Diego · doi:10.7270/q23r0xmc

BindingDB Entry 50016430: Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs.

BindingDB (2023) · UC San Diego · doi:10.7270/q2dn4921

BindingDB Entry 7925: The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.

BindingDB (2017) · UC San Diego · doi:10.7270/q2ng4pgd

Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Score, J., Hidalgo-Curtis, C., Jones, A. V., Winkelmann, N., Skinner, A., Ward, D., Zoi, K., Ernst, T., Stegelmann, F., Döhner, K., et al. (2012) · Blood · doi:10.1182/blood-2011-07-367243 · Cited by 177 · see citing works

Role of the Polycomb Methyltransferase Ezh1 in Myelodysplastic Syndrome Induced By Ezh2 Insufficiency

Aoyama, K., Mochizuki‐Kashio, M., Oshima, M., Koide, S., Nakajima‐Takagi, Y., Maeda, M., Sashida, G., & Iwama, A. (2016) · Blood · doi:10.1182/blood.v128.22.1968.1968

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Khan, S. N., Jankowska, A. M., Mahfouz, R. Z., Dunbar, A. J., Sugimoto, Y., Hosono, N., Hu, Z., Cheriyath, V., Vatolin, S., Przychodzen, B. P., et al. (2013) · Leukemia · doi:10.1038/leu.2013.80 · Cited by 132 · see citing works

Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner

Mochizuki‐Kashio, M., Aoyama, K., Sashida, G., Oshima, M., Tomioka, T., Muto, T., Wang, C., & Iwama, A. (2015) · Blood · doi:10.1182/blood-2015-03-634428 · Cited by 141 · see citing works

Mitotic recombination in haematological malignancy

Raghavan, M., Gupta, M., Molloy, G. Y., Chaplin, T., & Young, B. D. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.030 · Cited by 5 · see citing works